Cinctive Capital Management’s Akero Therapeutics AKRO Stock Holding History

Cinctive Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31,903	Closed	-$1.51M	–	391
2025 Q3	$1.51M	Buy	+31,903	New	+$1.54M	0.07%	275
2025 Q1	–	Sell	-67,964	Closed	-$1.89M	–	308
2024 Q4	$1.89M	Buy	67,964 +2,657	+4%	+$80.5K	0.1%	224
2024 Q3	$1.87M	Buy	+65,307	New	+$1.7M	0.1%	236

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cinctive Capital Management's AKRO Position: Q4 2025 in Review

Cinctive Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 31,903 shares — an estimated $1.51M sold.

Cinctive Capital Management first reported a position in AKRO in Q3 2024 and held it in 3 quarters. The position peaked at $1.89M in Q4 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Cinctive Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Cinctive Capital Management sold 31,903 Akero Therapeutics shares in Q4 2025, an estimated $1.51M.
Cinctive Capital Management first reported a position in Akero Therapeutics in Q3 2024 and held it in 3 quarters.
Cinctive Capital Management's Akero Therapeutics position peaked at $1.89M in Q4 2024.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.